60 Degree Pharmaceuticals announced that it will effect a one-for-four reverse stock split of its common stock, par value $0.0001 per share, that will become effective on January 20, 2026, at 12:01 AM Eastern Time, before the opening of trading on The Nasdaq Capital Market. 60 Degrees Pharma has requested that its Common Stock begin trading on January 20, 2026, on a post-reverse split basis on the Nasdaq under the existing symbol “SXTP“.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SXTP:
- 60 Degrees Pharma outlines growth strategy in investor webinar
- 60 Degrees announces detection of babesia infection in 24% of patients in study
- 60 Degrees Pharmaceuticals expanding Arakoda sales and marketing in 2026
- 60 Degrees announces central site for B-FREE study open for patient enrollment
- 60 Degrees Pharmaceuticals Faces Financial Challenges Amid Growth Efforts